[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]
[Article in
German]
- PMID: 202020
Item in Clipboard
[Therapeutic results using VP 16-213 alone or in combination with 5-fluorouracil in liver cancer (hepatoma)]
[Article in
German]
Schweiz Med Wochenschr.
.
Abstract
The podophyllotoxin derivative VP 16-213 was used as monotherapy in 6 patients and combined with 5-fluorouracil in another 6. Of the 12 patients treated, 11 had measurable tumor criteria and 5 of these responded to treatment. These responses were attributed mainly to the effects of VP 16-213. Patients responding to chemotherapy lived significantly longer than non-responders. Each case of objective tumor response was accompanied by subjective improvement. In view of these results, a more active approach to the treatment of hepatocellular carcinoma would seem to be justified.
Similar articles
-
The role of VP-16 in the treatment of small-cell lung cancer: studies of the West of Scotland Lung Cancer Group.Semin Oncol. 1985 Mar;12(1 Suppl 2):2-6. Semin Oncol. 1985. PMID: 2983433
-
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study.Cancer Treat Rep. 1977 Nov;61(8):1595-7. Cancer Treat Rep. 1977. PMID: 200359 No abstract available.
-
[Clinical study of low-dose cisplatin and 5-fluorouracil chemotherapy via implanted fusion port in 20 patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis].Gan To Kagaku Ryoho. 2007 May;34(5):729-34. Gan To Kagaku Ryoho. 2007. PMID: 17496446 Japanese.
-
[Etoposide. A new highly effective cytostatic agent in anaplastic small-cell bronchial carcinoma, other solid tumors and hemoblastoses].Dtsch Med Wochenschr. 1981 Aug 28;106(35):1105-9. doi: 10.1055/s-2008-1070465. Dtsch Med Wochenschr. 1981. PMID: 6266800 Review. German. No abstract available.
-
Podophyllotoxin derivative VP 16-213.Cancer Chemother Pharmacol. 1979;3(2):71-80. doi: 10.1007/BF00254976. Cancer Chemother Pharmacol. 1979. PMID: 389478 Review.
Cited by
-
Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by modulation of inflammatory and fibrogenic factors.Toxicol Res (Camb). 2019 May 22;8(4):560-567. doi: 10.1039/c9tx00103d. eCollection 2019 Jul 1. Toxicol Res (Camb). 2019. PMID: 31367338 Free PMC article.
-
Comparison of a water-soluble and a water-insoluble podophyllotoxin derivative in murine neoplasms.J Cancer Res Clin Oncol. 1979;95(3):233-7. doi: 10.1007/BF00410644. J Cancer Res Clin Oncol. 1979. PMID: 528564 Free PMC article.
-
VP16-213 (etoposide). A critical review of its activity.Cancer Chemother Pharmacol. 1982;7(2-3):81-5. doi: 10.1007/BF00254526. Cancer Chemother Pharmacol. 1982. PMID: 7044594 Review. No abstract available.
-
[Etoposide VP 16--213)--a podophyllotoxinderivative with high antitumor activity (author's transl)].Klin Wochenschr. 1981 Nov 2;59(21):1177-88. doi: 10.1007/BF01721212. Klin Wochenschr. 1981. PMID: 7031350 Clinical Trial. German.